EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CALB2 Expression Is Associated with Tumor Progression and Prognosis in Colorectal Adenocarcinoma

Feng Yang, Yizhou Liu, Na Luo, Qianxia Li, Guangyuan Hu

Genes · 25.04.2026 · 17 (5) · 510

DOI: 10.3390/genes17050510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 25.04.2026. Verfasst von Feng Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Adenocarcinoma, Biomarkers, Tumor, Calbindins. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Youth Science Foundation Project, National Natural Science Foundation of China, Youth Science Foundation Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Globally, colorectal adenocarcinoma (COAD) continues to be one of the most frequent contributors to cancer-associated deaths, pointing out an ongoing demand for robust biomarkers capable of reflecting disease advancement and predicting patient outcomes. Calbindin 2 (CALB2), a calcium-binding protein, has been implicated in tumor progression in several malignancies, but the precise functional involvement of this molecule in COAD remains insufficiently characterized. This study aimed to examine the clinical relevance and functional significance of CALB2 in COAD.

Methods

Clinical tissue-based analyses, bioinformatic analyses of publicly available datasets, in vitro and in vivo functional assays, and targeted metabolomic profiling were performed to evaluate CALB2 in COAD.

Results

Immunofluorescence analysis of a COAD tissue microarray revealed that CALB2 expression was more frequently detected in stage III tumors and was associated with the proliferation marker Ki67. The Cancer Genome Atlas (TCGA) cohort’s bioinformatic analyses revealed an increase in CALB2 expression with advancing pathological T stage, and it was associated with poorer overall survival. Functional experiments demonstrated that CALB2 expression accelerated tumor growth in vivo and promoted the migration and proliferation of colorectal adenocarcinoma cells in vitro. At the molecular level, altered CALB2 expression was associated with changes in epithelial–mesenchymal transition-related markers, p53 Ser33 phosphorylation, and amino acid-related metabolic profiles.

Conclusions

Collectively, these findings show a correlation between CALB2 expression and poor clinical outcomes and disease progression in colorectal adenocarcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsAdenocarcinomaBiomarkers, TumorCalbindinsHumansPrognosisAnimalsDisease ProgressionMaleGene Expression Regulation, NeoplasticMiceFemaleCell ProliferationCell Line, TumorCell MovementEpithelial-Mesenchymal TransitionMiddle Aged

Stichwörter der Autor:innen

CALB2amino acid metabolismcolorectal adenocarcinomatumor progression

Substanzen

Biomarkers, TumorCalbindins

Autor:innen und Institutionen

  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.

Förderung

  • Natural Science Foundation of China, Youth Science Foundation Project
  • National Natural Science Foundation of China, Youth Science Foundation Project

Zitieren

APA

Yang, F., Liu, Y., Luo, N., Li, Q., & Hu, G. (2026). CALB2 Expression Is Associated with Tumor Progression and Prognosis in Colorectal Adenocarcinoma. Genes, 17(5), 510. https://doi.org/10.3390/genes17050510

Vancouver

Yang F, Liu Y, Luo N, Li Q, Hu G. CALB2 Expression Is Associated with Tumor Progression and Prognosis in Colorectal Adenocarcinoma. Genes. 2026;17(5):510. doi:10.3390/genes17050510

BibTeX
@article{Yang2026,
  author = {Yang, Feng and Liu, Yizhou and Luo, Na and Li, Qianxia and Hu, Guangyuan},
  title = {CALB2 Expression Is Associated with Tumor Progression and Prognosis in Colorectal Adenocarcinoma},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {510},
  doi = {10.3390/genes17050510}
}
Kostenlos starten →